PERCEPTIVE ADVISORS LLC Q3 2017 Filing

Filed November 14, 2017

Portfolio Value

$2.6T

Holdings

134

Report Date

Q3 2017

Filing Type

13F-HR

All Holdings (134 positions)

#StockSharesValue% PortfolioType
101
EP3ORASURE TECHNOLOGIES INC
54,729$1.2B0.05%
102
EX9EXELIXIS INC
46,361$1.1B0.04%
103
STLAFIAT CHRYSLER AUTOMOBILES N
62,000$1.1B0.04%
104
LNTHLANTHEUS HLDGS INC
53,763$957.0M0.04%
105
AZURRX BIOPHARMA INC
227,272$907.0M0.03%
106
CNCCENTENE CORP DEL
7,726$748.0M0.03%
107
VYGRVOYAGER THERAPEUTICS INC
34,604$712.0M0.03%
108
INCYINCYTE CORP
105,619$691.0M0.03%Call
109
RACEFERRARI N V
6,200$685.0M0.03%
110
PROTEON THERAPEUTICS INC
334,116$668.0M0.03%
111
VNDAVANDA PHARMACEUTICALS INC
36,232$649.0M0.02%
112
HSKAEURHESKA CORP
7,300$643.0M0.02%
113
AFWALIGN TECHNOLOGY INC
3,448$642.0M0.02%
114
KERYX BIOPHARMACEUTICALS INC
83,386$592.0M0.02%
115
ONCBEIGENE LTD
5,700$590.0M0.02%
116
ATRAGBXATARA BIOTHERAPEUTICS INC
35,106$581.0M0.02%
117
PRAHPRA HEALTH SCIENCES INC
7,427$566.0M0.02%
118
ESPRESPERION THERAPEUTICS INC NE
10,769$540.0M0.02%
119
IMGNEURIMMUNOGEN INC
70,126$536.0M0.02%
120
PARATEK PHARMACEUTICALS INC
21,186$532.0M0.02%
121
INOVALON HLDGS INC
30,000$511.0M0.02%
122
CUTREURCUTERA INC
11,981$495.0M0.02%
123
TDOCTELADOC INC
14,641$485.0M0.02%
124
FGENEURFIBROGEN INC
8,593$462.0M0.02%
125
ACHAOGEN INC
27,551$439.0M0.02%
126
NABRIVA THERAPEUTICS PLC
52,570$431.0M0.02%
127
PORTOLA PHARMACEUTICALS INC
7,870$425.0M0.02%
128
PERNIX THERAPEUTICS HLDGS IN
1,000,000$420.0M0.02%
129
ZOSANO PHARMA INC
500,000$412.0M0.02%
130
MOHMOLINA HEALTHCARE INC
50,000$345.0M0.01%Call
131
HCMHUTCHISON CHINA MEDITECH LTD
10,000$273.0M0.01%
132
ACASTI PHARMA INC
186,559$267.0M0.01%
133
SG7SAGE THERAPEUTICS INC
215,000$178.0M0.01%Call
134
SENS1GBPSENSEONICS HOLDINGS INC
50,000$160.0M0.01%
135
ISIIONIS PHARMACEUTICALS INC
60,000$24.0M0.00%Call
PreviousPage 2 of 2